Novartis partners with Canadian medical marijuana company Tilray

By zaymalz malz

Tilray, a Canadian medical marijuana company has signed a new deal with leading Swiss multinational pharmaceutical company Novartis to become the firm’s exclusive supplier of non-smokeable medical cannabis products for its Canadian subsidiary, Sandoz.

Tilray was the first medical cannabis firm to obtain a Good Manufacturing Practice certification (cGMP) in accordance with the standards of the European Medicine Agency. As a leader in the market, Tilray currently supplies tens of thousands of patients with its product across ten countries.

See also:

“This agreement is a major milestone on the long road to legitimizing medical cannabis as conventional medicine,” said Brendan Kennedy, Tilray’s Chief Executive Officer.

“Tilray is pleased to be, what we believe is, the first federally licensed producer of medical cannabis to form a strategic alliance with a local affiliate of a global pharmaceutical company to improve the availability and quality of medical cannabis products for Canadian patients in need.”

In addition to becoming the exclusive supplier of Sandoz, Tilray will also partner with the firm to develop new cannabis-based products that offer an alternative to smokable products that will then be distributed to Canadian hospitals and pharmacies.


Featured Articles

Broadridge study reveals huge impact of AI on C-suite

Broadridge Financial Solutions spoke to 500 C-suite executives from across the globe, many of whom said AI was significantly changing the way they work

PwC's Kathryn Kaminsky – the role of boards on social issues

As Vice Chair Trust Solutions Co-Leader at PwC, Kathryn Kaminsky says boards play an important role in helping businesses take action on social issues

Why your business needs a Chief Transformation Officer

Responsible for driving growth and change, the Chief Transformation Officer is the latest addition to the C-suite as business undergoes major change

12 top AI and ML trends for the enterprise in 2023 – Dataiku

Technology & AI

From NYC to Hong Kong, the rise of the private members' club

Leadership & Strategy

Meet the CEO: Jill Stelfox of Panzura, exclusive interview

Leadership & Strategy